Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors

Organic Letters

Volumn 7, Issue 21, 2005, Pages 4753-4756

  Stevens, Kirk L ^a   Jung, David K ^a   Alberti, Michael J ^a   Badiang, Jennifer G ^a   Peckham, Gregory E ^a   Veal, Jim M ^a,b   Cheung, Mui ^a   Harris, Philip A ^a   Chamberlain, Stanley D ^a   Peel, Michael R ^a,c  

^a GLAXOSMITHKLINE   (United States)

^b Serenex Inc   (United States)

^c SCYNEXIS Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; MOLECULAR STRUCTURE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27144513812     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0519745     Document Type: Article

References (15)

1. (a) Adams, J. L.; Badger, A. M.; Kumar, S.; Lee, J. C. Prog. Med. Chem. 2001, 38, 1.
2. (b) Dumas, J.; Sibley, R.; Riedl, B.; Monahan, M. K.; Lee, W.; Lowinger, T. B.; Redman, A. M.; Johnson, J. S.; Kingery-Wood, J.; Scott, W. J.; Smith, R. A.; Bobko, M.; Schoenleber, R.; Ranges, G. E.; Housley, T. J.; Bhargava, A.; Wilhelm, S. M.; Shrikhande, A. Bioorg. Med. Chem. Lett. 2000, 10 (18), 2047.
3. (c) Pargellis, C.; Tong, L.; Churchill, L.; Cirillo, P. F.; Gilmore, T.; Graham, A. G.; Grob, P. M.; Hickey, E. R.; Moss, N.; Pav, S.; Regan, J. Nat. Struct. Biol. 2002, 9, 268.
4. (a) Wilson, K. P.; Fitzgibbon, M. J.; Caron, P. R.; Griffith, J. P.; Chen, W.; McCaffrey, P. G.; Chambers, S. P.; Su, M. S.-S. J. Biol. Chem. 1996, 271, 27696.
5. (b) Wang, Z.; Harkins, P. C.; Ulevitch, R. J.; Han, J.; Cobb, M. H.; Goldsmith, E. J. Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (6), 2327.
6. (c) Tong, L.; Pav, S.; White, D. M.; Rogers, S.; Crane, K. M.; Cywin, C. L.; Brown, M. L.; Pargellis, C. A. Nat. Struct. Biol. 1997, 4, 311.
7. (a) Awano, K.; Suzue, S.; Segawa, M. Chem. Pharm. Bull. 1986, 34, 2828.
8. (b) Miki, Y.; Yagi, S.; Hachiken, H.; Ikeda, M. Heterocycles 1994, 38, 1881.
9. (c) Koeckritz, P.; Riemer, B.; Michler, A.; Hassoun, A.; Liebscher, J. J. Heterocycl. Chem. 1994, 31, 1157.
10. (d) Bondo, H. J.; Weis, J.; Suzdak, P. D.; Eskesen, K. Bioorg. Med. Chem. Lett. 1994, 4, 695.
11. HOSA = Hydroxylamine O-Sulfonic Acid; MSH = Mesityl O-Hydroxylamine.
12. Fitzgerald, R. N.; Jung, D. K.; Eaddy, J. F. PCT Int. Appl. 2001, WO0183479A2.
13. Ryang, H.-S.; Sakurai, H. J. Chem. Soc., Chem. Commun. 1972, 77.
14. (a) Palat, K.; Celadnik, M.; Danek, J.; Varkonda, S. Collect. Czech. Chem. Commun. 1992, 57, 1127.
15. (b) Kreutzberger, A.; Tantawy, A. Arch. Pharm. 1979, 312, 426.